Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...

Eli Lilly has shared positive two-year results from an open-label extension (OLE) study of Omvoh (mirikizumab-mrkz) in active ...

Bio-Thera will obtain an upfront payment of $21m and could earn up to $143.5m in development and commercial milestones.

Class A shares underperformed the MSCI ACWI ex USA Index. During the quarter, we initiated four new positions and exited one ...

Queensland has the third highest prevalence of a debilitating bowel disease that impacts 180,000 Australians, costing sufferers thousands of dollars in medical expenses.

Republican lawmakers have criticized institutions for allegedly misusing taxpayer money, citing cases such as the 2020 ...

GENERALLY, A CHRONIC illness is a medical condition that lasts for six months or longer, usually requires ongoing care and treatment, and may limit your daily activities, says Sumanth Prabhu, M.D., ...

Bio-Thera had entered into an exclusive licensing agreement with STADA Arzneimittel AG to commercialize BAT2506 in the European Union (UK), the United Kingdom (UK), Switzerland, and selected other ...

A recent major OECD report has warned of a looming crisis in the European health workforce. In the third in our series on the ...

HC Wainwright reissued their buy rating on shares of Immix Biopharma (NASDAQ:IMMX – Free Report) in a report released on ...

One woman has shared how she started getting violent allergic reactions when eating certain foods. Lisa O'Brien said she started getting a red rosacea-like rash across her face which followed shortly ...

Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seven brokerages that are currently covering the company, Marketbeat reports. Two ...